Â¥
13.90
May 10
Business Description
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd
ISIN : CNE100002WP3
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.79 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.46 | |||||
Debt-to-EBITDA | -6.91 | |||||
Interest Coverage | 9.11 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.86 | |||||
Beneish M-Score | -3.17 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.9 | |||||
3-Year Book Growth Rate | 15 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 74.78 | |||||
9-Day RSI | 70.36 | |||||
14-Day RSI | 65.52 | |||||
6-1 Month Momentum % | 1.27 | |||||
12-1 Month Momentum % | -10.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.46 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.71 | |||||
Days Inventory | 898.88 | |||||
Days Sales Outstanding | 95.74 | |||||
Days Payable | 100.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.83 | |||||
Dividend Payout Ratio | 0.24 | |||||
3-Year Dividend Growth Rate | -20.7 | |||||
Forward Dividend Yield % | 0.83 | |||||
5-Year Yield-on-Cost % | 1.84 | |||||
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 0.78 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.84 | |||||
Operating Margin % | 20.57 | |||||
Net Margin % | -9.5 | |||||
FCF Margin % | 34.96 | |||||
ROE % | -5.43 | |||||
ROA % | -3.31 | |||||
ROIC % | 7.24 | |||||
ROC (Joel Greenblatt) % | -6.22 | |||||
ROCE % | -5.49 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 29.26 | |||||
Shiller PE Ratio | 40.88 | |||||
PS Ratio | 6.12 | |||||
PB Ratio | 3.76 | |||||
Price-to-Tangible-Book | 4.16 | |||||
Price-to-Free-Cash-Flow | 17.67 | |||||
Price-to-Operating-Cash-Flow | 13.08 | |||||
EV-to-EBIT | -58.47 | |||||
EV-to-EBITDA | -58.47 | |||||
EV-to-Revenue | 6.35 | |||||
EV-to-FCF | 17.89 | |||||
Price-to-Projected-FCF | 4.91 | |||||
Price-to-Graham-Number | 2.33 | |||||
Price-to-Net-Current-Asset-Value | 5.99 | |||||
Earnings Yield (Greenblatt) % | -1.71 | |||||
FCF Yield % | 5.65 | |||||
Forward Rate of Return (Yacktman) % | 17.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 3,628.176 | ||
EPS (TTM) (Â¥) | -0.22 | ||
Beta | 1.26 | ||
Volatility % | 47.72 | ||
14-Day RSI | 65.52 | ||
14-Day ATR (Â¥) | 0.488536 | ||
20-Day SMA (Â¥) | 13.074 | ||
12-1 Month Momentum % | -10.4 | ||
52-Week Range (Â¥) | 10.75 - 16.4 | ||
Shares Outstanding (Mil) | 1,616.65 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Frequently Asked Questions
What is Nanjing King-Friend Biochemical Pharmaceutical Co Ltd(SHSE:603707)'s stock price today?
When is next earnings date of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd(SHSE:603707)?
Does Nanjing King-Friend Biochemical Pharmaceutical Co Ltd(SHSE:603707) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |